CSIMarket
 
Gb Sciences Inc  (GBLX)
Other Ticker:  
 
    Sector  Energy    Industry Oil And Gas Production
   Industry Oil And Gas Production
   Sector  Energy
 
Price: $0.0064 $0.00 -1.538%
Day's High: $0.0074 Week Perf: 1.59 %
Day's Low: $ 0.01 30 Day Perf: 12.28 %
Volume (M): 28 52 Wk High: $ 0.02
Volume (M$): $ 0 52 Wk Avg: $0.01
Open: $0.01 52 Wk Low: $0.01



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 403
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Gb Sciences Inc
Gb Sciences Inc. is a biotechnology company based in Las Vegas, Nevada. They specialize in developing innovative cannabis-based therapies for various medical conditions. The company is focused on using their proprietary plant-based technologies to create consistent and high-quality products. Gb Sciences Inc. is also dedicated to conducting rigorous research and partnering with academic institutions to advance the understanding and application of cannabis in medicine.


   Company Address: 9205 W. Russell Road, Suite 240 Las Vegas 89148 NV
   Company Phone Number: 721-0297   Stock Exchange / Ticker: GBLX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Gb Sciences Inc

Gb Sciences Inc Discloses Dissatisfactory Performance with an Operating Deficit of $-0.529623 million during Recent Fiscal period

Financial News Report:
Gb Sciences Inc Announces Operating Shortfall of $-0.529623 Million in Latest Fiscal Period
As the earnings cycle for fiscal January to March 31, 2023 resumes, several companies, including Gb Sciences Inc, have disclosed their earnings. GBLX, Gb Sciences Inc's ticker symbol, recently announced an operating shortfall of $-0.529623 million for the most recent fiscal period. This report has captured the attention of the market, which now expects further revenue streams to be generated in the upcoming cycle. However, the market seems to be paying less attention to the organizational and operational excellence of the Oil And Gas Production company.
Despite the operating shortfall, Gb Sciences Inc has shown cost-effective operations by significantly reducing the diminishing returns to $-2.865 million during this fiscal period. The management's efforts in cost-cutting measures have positively impacted the company's financial performance. Investors anticipate improved financial results by the next reporting cycle, which is scheduled for August 10, 2023.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com